Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial
Ray-Coquard, I., Leary, A., Pignata, S., Cropet, C., González-Martín, A., Marth, C., Nagao, S., Vergote, I., Colombo, N., Mäenpää, J., Selle, F., Sehouli, J., Lorusso, D., Guerra Alia, E.M., Bogner, G., Yoshida, H., Lefeuvre-Plesse, C., Buderath, P., Mosconi, A.M., Lortholary, A., Burges, A., Medioni, J., El-Balat, A., Rodrigues, M., Park-Simon, T.-W., Dubot, C., Denschlag, D., You, B., Pujade-Lauraine, E., Harter, P.
Published in Annals of oncology (01.08.2023)
Published in Annals of oncology (01.08.2023)
Get full text
Journal Article
Translational studies within the TAMRAD randomized GINECO trial: evidence for mTORC1 activation marker as a predictive factor for everolimus efficacy in advanced breast cancer
Treilleux, I., Arnedos, M., Cropet, C., Wang, Q., Ferrero, J.-M., Abadie-Lacourtoisie, S., Levy, C., Legouffe, E., Lortholary, A., Pujade-Lauraine, E., Bourcier, A.-V., Eymard, J.-C., Spaeth, D., Bachelot, T.
Published in Annals of oncology (01.01.2015)
Published in Annals of oncology (01.01.2015)
Get full text
Journal Article
Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I–type II study from the GINECO group
Heudel, P-E, Fabbro, M, Roemer-Becuwe, C, Kaminsky, M C, Arnaud, A, Joly, F, Roche-Forestier, S, Meunier, J, Foa, C, You, B, Priou, F, Tazi, Y, Floquet, A, Selle, F, Berton-Rigaud, D, Lesoin, A, Kalbacher, E, Lortholary, A, Favier, L, Treilleux, I, Ray-Coquard, I
Published in British journal of cancer (01.01.2017)
Published in British journal of cancer (01.01.2017)
Get full text
Journal Article
Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study
Pivot, X., Spano, J.P., Espie, M., Cottu, P., Jouannaud, C., Pottier, V., Moreau, L., Extra, J.M., Lortholary, A., Rivera, P., Spaeth, D., Attar-Rabia, H., Benkanoun, C., Dima-Martinez, L., Esposito, N., Gligorov, J.
Published in European journal of cancer (1990) (01.09.2017)
Published in European journal of cancer (1990) (01.09.2017)
Get full text
Journal Article
Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study
Joly, F., Ahmed-Lecheheb, D., Kalbacher, E., Heutte, N., Clarisse, B., Grellard, J.M., Gernier, F., Berton-Rigaud, D., Tredan, O., Fabbro, M., Savoye, A.M., Kurtz, J.E., Alexandre, J., Follana, P., Delecroix, V., Dohollou, N., Roemer-Becuwe, C., De Rauglaudre, G., Lortholary, A., Prulhiere, K., Lesoin, A., Zannetti, A., N’Guyen, S., Trager-Maury, S., Chauvenet, L., Abadie Lacourtoisie, S., Gompel, A., Lhommé, C., Floquet, A., Pautier, P.
Published in Annals of oncology (01.05.2019)
Published in Annals of oncology (01.05.2019)
Get full text
Journal Article
ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer
Van Gorp, T., Cibula, D., Lv, W., Backes, F., Ortaç, F., Hasegawa, K., Lindemann, K., Savarese, A., Laenen, A., Kim, Y.M., Bodnar, L., Barretina-Ginesta, M.-P., Gilbert, L., Pothuri, B., Chen, X., Flores, M.B., Levy, T., Colombo, N., Papadimitriou, C., Buchanan, T., Hanker, L.C., Eminowicz, G., Rob, L., Black, D., Lichfield, J., Lin, G., Orlowski, R., Keefe, S., Lortholary, A., Slomovitz, B.
Published in Annals of oncology (14.09.2024)
Published in Annals of oncology (14.09.2024)
Get full text
Journal Article
Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials
MAJOR, P, LORTHOLARY, A, SEAMAN, J, HON, J, ABDI, E, MILLS, G, MENSSEN, H. D, YUNUS, F, BELL, R, BODY, J, QUEBE-FEHLING, E
Published in Journal of clinical oncology (15.01.2001)
Published in Journal of clinical oncology (15.01.2001)
Get full text
Journal Article
Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab
Pierga, J.-Y., Bidard, F.-C., Autret, A., Petit, T., Andre, F., Dalenc, F., Levy, C., Ferrero, J.-M., Romieu, G., Bonneterre, J., Lerebours, F., Bachelot, T., Kerbrat, P., Campone, M., Eymard, J.-C., Mouret-Reynier, M.-A., Gligorov, J., Hardy-Bessard, A.-C., Lortholary, A., Soulie, P., Boher, J.-M., Proudhon, C., Charafe-Jaufret, E., Lemonnier, J., Bertucci, F., Viens, P.
Published in Annals of oncology (01.01.2017)
Published in Annals of oncology (01.01.2017)
Get full text
Journal Article
Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens (GINECO)
Lortholary, A., Largillier, R., Weber, B., Gladieff, L., Alexandre, J., Durando, X., Slama, B., Dauba, J., Paraiso, D., Pujade-Lauraine, E.
Published in Annals of oncology (01.02.2012)
Published in Annals of oncology (01.02.2012)
Get full text
Journal Article
Cabazitaxel in patients with advanced solid tumours: Results of a Phase I and pharmacokinetic study
Diéras, V, Lortholary, A, Laurence, V, Delva, R, Girre, V, Livartowski, A, Assadourian, S, Semiond, D, Pierga, J.Y
Published in European journal of cancer (1990) (01.01.2013)
Published in European journal of cancer (1990) (01.01.2013)
Get full text
Journal Article
Phase II study of olaparib + durvalumab (MEDIOLA): Updated results in germline BRCA-mutated platinum-sensitive relapsed (PSR) ovarian cancer (OC)
Drew, Y., Kaufman, B., Banerjee, S., Lortholary, A., Hong, S.H., Park, Y.H., Zimmermann, S., Roxburgh, P., Ferguson, M., Alvarez, R.H., Domchek, S., Gresty, C., Angell, H.K., Ros, V Rocher, Meyer, K., Lanasa, M., Herbolsheimer, P., de Jonge, M.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Sefety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERMIONE non-interventional prospective study
Jacquin, J.-P.P., Uwer, L., Savignoni, A., Ferrero, J.-M., Lortholary, A., Solub, D., Attar-Rabia, H., Deblay, S., Pibre, S., Belkacemi, Y.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network
Derquin, F., Floquet, A., Hardy-Bessard, A.C., Edeline, J., Lotz, J.P., Alexandre, J., Pautier, P., Angeles, M.A., Delanoy, N., Lefeuvre-Plesse, C., Cancel, M., Treilleux, I., Augereau, P., Lavoue, V., Kalbacher, E., Berton Rigaud, D., Selle, F., Nadeau, C., Gantzer, J., Joly, F., Guillemet, C., Pomel, C., Favier, L., Abdeddaim, C., Venat-Bouvet, L., Provansal, M., Fabbro, M., Kaminsky, M.C., Lortholary, A., Lecuru, F., Coquard, I. Ray, de La Motte Rouge, T.
Published in Gynecologic oncology (01.09.2020)
Published in Gynecologic oncology (01.09.2020)
Get full text
Journal Article
A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinoma
Selle, F., Sevin, E., Ray-Coquard, I., Mari, V., Berton-Rigaud, D., Favier, L., Fabbro, M., Lesoin, A., Lortholary, A., Pujade-Lauraine, E.
Published in Annals of oncology (01.11.2014)
Published in Annals of oncology (01.11.2014)
Get full text
Journal Article
Phase II multicenter study of larotaxel (XRP9881), a novel taxoid, in patients with metastatic breast cancer who previously received taxane-based therapy
Diéras, V., Limentani, S., Romieu, G., Tubiana-Hulin, M., Lortholary, A., Kaufman, P., Girre, V., Besenval, M., Valero, V.
Published in Annals of oncology (01.07.2008)
Published in Annals of oncology (01.07.2008)
Get full text
Journal Article
FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial
Ladoire, S., Mignot, G., Dalban, C., Chevriaux, A., Arnould, L., Rébé, C., Apetoh, L., Boidot, R., Penault-Llorca, F., Fumoleau, P., Roché, H., Spielmann, M., Levy, C., Lortholary, A., Eichler, F., Mesleard, C., Bonnetain, F., Ghiringhelli, F.
Published in Annals of oncology (01.10.2012)
Published in Annals of oncology (01.10.2012)
Get full text
Journal Article
Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: Results of the randomised GEFCAPI 02 trial
Gross-Goupil, M, Fourcade, A, Blot, E, Penel, N, Négrier, S, Culine, S, Chaigneau, L, Lesimple, T, Priou, F, Lortholary, A, Kaminsky, M.C, Provencal, J, Voog, E, Bouzy, J, Laplanche, A, Fizazi, K
Published in European journal of cancer (1990) (01.03.2012)
Published in European journal of cancer (1990) (01.03.2012)
Get full text
Journal Article
Long term HER2+ metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORA
Spano, J.-P, Beuzeboc, P, Coeffic, D, Arnould, L, Lortholary, A, Andre, F, Ferrero, J.-M
Published in Breast (Edinburgh) (01.08.2015)
Published in Breast (Edinburgh) (01.08.2015)
Get full text
Journal Article
2755 First real life data on Olaparib in BRCA1/2 mutated Platinum-Sensitive Relapsed (PSR) Epithelial Ovarian Cancer (EOC) in France: Analysis of 52 patients (pts) enrolled in the French Temporary Authorization for Use (ATU)
De La Motte Rouge, T, Pautier, P, Alexandre, J, Ray-Coquard, I, Cottu, P, Rodrigues, M, Follana, P, Floquet, A, Lortholary, A, Heudel, P.E, Combe, P, Joly, F, Suau, D, Maribas, D, Licour, M, Porte, I. De La, Varoqueaux, N, Pujade-Lauraine, E
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Correlation Between Uracil and Dihydrouracil Plasma Ratio, Fluorouracil (5-FU) Pharmacokinetic Parameters, and Tolerance in Patients With Advanced Colorectal Cancer: A Potential Interest for Predicting 5-FU Toxicity and Determining Optimal 5-FU Dosage
GAMELIN, E, BOISDRON-CELLE, M, GUERIN-MEYER, V, DELVA, R, LORTHOLARY, A, GENEVIEVE, F, LARRA, F, IFRAH, N, ROBERT, J
Published in Journal of clinical oncology (01.04.1999)
Published in Journal of clinical oncology (01.04.1999)
Get full text
Journal Article